Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, driving development of life-saving medicines that would otherwise be too costly to produce. Learn how it works, who benefits, and why it's here to stay.
Tag: drug development incentives
The Latest
-
Health and Medicine
Chlorthalidone and Heart Disease Prevention: What the Evidence Says (2025)
Does chlorthalidone help prevent heart disease and stroke? Clear, evidence-based breakdown of benefits, risks, dosing, and how it compares to HCTZ in 2025. -
Health and Medicine
Phenytoin and Generics: What You Need to Know About Therapeutic Drug Monitoring
Phenytoin has a narrow therapeutic window and nonlinear kinetics, making generic switches risky. Learn when and how to monitor levels, correct for protein binding, and avoid deadly toxicity. -
Health and Wellness
Pumping and Storing Breast Milk While Taking Medication: What You Really Need to Know
Learn the truth about pumping and storing breast milk while taking medication. Most meds are safe-dumping milk is usually unnecessary and can hurt your supply. Find out what’s really safe and how to time doses correctly. -
Health and Medicine
How Muscle Spasms Relate to Multiple Sclerosis - Causes, Symptoms, and Management
Explore why muscle spasms are common in multiple sclerosis, their triggers, diagnosis, and effective management strategies for better daily living. -
Health and Medicine
Blood Thinners and Anticoagulants: Stroke Prevention Options Explained
Learn how blood thinners prevent stroke in atrial fibrillation, comparing warfarin and DOACs like apixaban and rivaroxaban - including effectiveness, cost, side effects, and who should use each.